⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 1, 2005Expert Opinion on Drug Safety

The use of electrocardiograms in clinical trials: a public discussion of the proposed ICH E14 regulatory guidance

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

ICIcilio CaveroTotal (France)WCWilliam CrumbNova Research Company (United States)

Discussion

Loading...

Member takes

Implication

Nonclinical QT tests merit cautious regulatory use; leaves open their precise clinical predictability pending further validation.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cavero et al. (2005) studied this question.

synapsesocial.com/papers/6a73b1d6d3d4e530dbfb7929 https://doi.org/10.1517/14740338.4.4.795

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications Report on a Policy Conference of the European Society of Cardiology2000 · 487 citations
2Drug Block of I Kr : Model Systems and Relevance to Human Arrhythmias2001 · 172 citations
3Risk of torsades de pointes with non-cardiac drugs2000 · 155 citations
4Cisapride-Induced Transmural Dispersion of Repolarization and Torsade de Pointes in the Canine Left Ventricular Wedge Preparation During Epicardial Stimulation2003 · 121 citations
5Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic2001 · 508 citations